Method for the production of bacterial toxins
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsMilan S. Blake, John A. Bogdan, Jr., Javier Nazario-Larrieu
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
Claims6
A method for producing pertussis toxin comprising
- cultivating Bordetella pertussis in a culture in the presence of (1) a reduced concentration of cysteine, wherein the reduced concentration is 0.04 to 0.1 grams of cysteine per liter, thereby reducing the concentration of sulfate ions from the metabolism of cysteine, and (2) a metal salt to sequester sulfate ions, wherein the metal is selected from the group consisting of Pb(II), Sr(II), Ag(II), and Ba(II), and
- isolating the pertussis toxin from the culture.
Dependencies are inferred from the claim text.